Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice.

Journal of lipid research

van Eenige R, Ying Z, Tambyrajah L, Pronk ACM, Blomberg N, Giera M, Wang Y, Coskun T, van der Stelt M, Rensen PCN, Kooijman S.
PMID: 33766515
J Lipid Res. 2021 Mar 23;62:100070. doi: 10.1016/j.jlr.2021.100070. Epub 2021 Mar 23.

Pharmacological blockade of the cannabinoid type 1 receptor, a G protein-coupled receptor expressed in the central nervous system and various peripheral tissues, reverses diet-induced obesity and dyslipidemia through the reduction of food intake and altered nutrient partitioning. This strategy...

Cite
van Eenige R, Ying Z, Tambyrajah L, et al. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. J Lipid Res. 2021;62:100070doi: 10.1016/j.jlr.2021.100070.
van Eenige, R., Ying, Z., Tambyrajah, L., Pronk, A. C. M., Blomberg, N., Giera, M., Wang, Y., Coskun, T., van der Stelt, M., Rensen, P. C. N., & Kooijman, S. (2021). Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. Journal of lipid research, 62100070. https://doi.org/10.1016/j.jlr.2021.100070
van Eenige, Robin, et al. "Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice." Journal of lipid research vol. 62 (2021): 100070. doi: https://doi.org/10.1016/j.jlr.2021.100070
van Eenige R, Ying Z, Tambyrajah L, Pronk ACM, Blomberg N, Giera M, Wang Y, Coskun T, van der Stelt M, Rensen PCN, Kooijman S. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. J Lipid Res. 2021 Mar 23;62:100070. doi: 10.1016/j.jlr.2021.100070. Epub 2021 Mar 23. PMID: 33766515; PMCID: PMC8082266.
Copy Download .nbib Format: NLM
Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice.

Journal of lipid research

van Eenige R, Ying Z, Tambyrajah L, Pronk ACM, Blomberg N, Giera M, Wang Y, Coskun T, van der Stelt M, Rensen PCN, Kooijman S.
PMID: 33766515
J Lipid Res. 2021;62:100070. doi: 10.1016/j.jlr.2021.100070. Epub 2021 Mar 23.

Pharmacological blockade of the cannabinoid type 1 receptor, a G protein-coupled receptor expressed in the central nervous system and various peripheral tissues, reverses diet-induced obesity and dyslipidemia through the reduction of food intake and altered nutrient partitioning. This strategy...

Cite
van Eenige R, Ying Z, Tambyrajah L, et al. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. J Lipid Res. 2021;62:100070doi: 10.1016/j.jlr.2021.100070.
van Eenige, R., Ying, Z., Tambyrajah, L., Pronk, A. C. M., Blomberg, N., Giera, M., Wang, Y., Coskun, T., van der Stelt, M., Rensen, P. C. N., & Kooijman, S. (2021). Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. Journal of lipid research, 62100070. https://doi.org/10.1016/j.jlr.2021.100070
van Eenige, Robin, et al. "Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice." Journal of lipid research vol. 62 (2021): 100070. doi: https://doi.org/10.1016/j.jlr.2021.100070
van Eenige R, Ying Z, Tambyrajah L, Pronk ACM, Blomberg N, Giera M, Wang Y, Coskun T, van der Stelt M, Rensen PCN, Kooijman S. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. J Lipid Res. 2021;62:100070. doi: 10.1016/j.jlr.2021.100070. Epub 2021 Mar 23. PMID: 33766515; PMCID: PMC8082266.
Copy Download .nbib Format: NLM
Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice.

Journal of lipid research

van Eenige R, Ying Z, Tambyrajah L, Pronk ACM, Blomberg N, Giera M, Wang Y, Coskun T, van der Stelt M, Rensen PCN, Kooijman S.
PMID: 33766515
J Lipid Res. 2021;62:100070. doi: 10.1016/j.jlr.2021.100070. Epub 2021 Mar 23.

Pharmacological blockade of the cannabinoid type 1 receptor, a G protein-coupled receptor expressed in the central nervous system and various peripheral tissues, reverses diet-induced obesity and dyslipidemia through the reduction of food intake and altered nutrient partitioning. This strategy...

Cite
van Eenige R, Ying Z, Tambyrajah L, et al. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. J Lipid Res. 2021;62:100070doi: 10.1016/j.jlr.2021.100070.
van Eenige, R., Ying, Z., Tambyrajah, L., Pronk, A. C. M., Blomberg, N., Giera, M., Wang, Y., Coskun, T., van der Stelt, M., Rensen, P. C. N., & Kooijman, S. (2021). Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. Journal of lipid research, 62100070. https://doi.org/10.1016/j.jlr.2021.100070
van Eenige, Robin, et al. "Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice." Journal of lipid research vol. 62 (2021): 100070. doi: https://doi.org/10.1016/j.jlr.2021.100070
van Eenige R, Ying Z, Tambyrajah L, Pronk ACM, Blomberg N, Giera M, Wang Y, Coskun T, van der Stelt M, Rensen PCN, Kooijman S. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice. J Lipid Res. 2021;62:100070. doi: 10.1016/j.jlr.2021.100070. Epub 2021 Mar 23. PMID: 33766515; PMCID: PMC8082266.
Copy Download .nbib Format: NLM
High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue.

Frontiers in physiology

Kuipers EN, Kantae V, Maarse BCE, van den Berg SM, van Eenige R, Nahon KJ, Reifel-Miller A, Coskun T, de Winther MPJ, Lutgens E, Kooijman S, Harms AC, Hankemeier T, van der Stelt M, Rensen PCN, Boon MR.
PMID: 30687125
Front Physiol. 2019 Jan 10;9:1913. doi: 10.3389/fphys.2018.01913. eCollection 2018.

The endocannabinoid system (ECS) controls energy balance by regulating both energy intake and energy expenditure. Endocannabinoid levels are elevated in obesity suggesting a potential causal relationship. This study aimed to elucidate the rate of dysregulation of the ECS, and...

Cite
Kuipers EN, Kantae V, Maarse BCE, et al. High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue. Front Physiol. 2019;9:1913doi: 10.3389/fphys.2018.01913.
Kuipers, E. N., Kantae, V., Maarse, B. C. E., van den Berg, S. M., van Eenige, R., Nahon, K. J., Reifel-Miller, A., Coskun, T., de Winther, M. P. J., Lutgens, E., Kooijman, S., Harms, A. C., Hankemeier, T., van der Stelt, M., Rensen, P. C. N., & Boon, M. R. (2018). High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue. Frontiers in physiology, 91913. https://doi.org/10.3389/fphys.2018.01913
Kuipers, Eline N, et al. "High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue." Frontiers in physiology vol. 9 (2018): 1913. doi: https://doi.org/10.3389/fphys.2018.01913
Kuipers EN, Kantae V, Maarse BCE, van den Berg SM, van Eenige R, Nahon KJ, Reifel-Miller A, Coskun T, de Winther MPJ, Lutgens E, Kooijman S, Harms AC, Hankemeier T, van der Stelt M, Rensen PCN, Boon MR. High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue. Front Physiol. 2019 Jan 10;9:1913. doi: 10.3389/fphys.2018.01913. eCollection 2018. PMID: 30687125; PMCID: PMC6335353.
Copy Download .nbib Format: NLM
Pressure dependence of Tc and Hc2 of YBa2Cu4O8.

Physical review. B, Condensed matter

Griessen R, Scholtz JJ, van Eenige EN, Wijngaarden RJ.
PMID: 10001859
Phys Rev B Condens Matter. 1992 Feb 01;45(6):3077-3082. doi: 10.1103/physrevb.45.3077.

No abstract available.

Cite
Griessen R, Scholtz JJ, van Eenige EN, et al. Pressure dependence of Tc and Hc2 of YBa2Cu4O8. Phys Rev B Condens Matter. 1992;45(6):3077-3082doi: 10.1103/physrevb.45.3077.
Griessen, R., Scholtz, J. J., van Eenige EN, & Wijngaarden, R. J. (1992). Pressure dependence of Tc and Hc2 of YBa2Cu4O8. Physical review. B, Condensed matter, 45(6), 3077-3082. https://doi.org/10.1103/physrevb.45.3077
Griessen, et al. "Pressure dependence of Tc and Hc2 of YBa2Cu4O8." Physical review. B, Condensed matter vol. 45,6 (1992): 3077-3082. doi: https://doi.org/10.1103/physrevb.45.3077
Griessen R, Scholtz JJ, van Eenige EN, Wijngaarden RJ. Pressure dependence of Tc and Hc2 of YBa2Cu4O8. Phys Rev B Condens Matter. 1992 Feb 01;45(6):3077-3082. doi: 10.1103/physrevb.45.3077. PMID: 10001859.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries